{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:03:58Z","timestamp":1791810238863,"version":"4.3.4"},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer US","isbn-type":[{"value":"9781071634080","type":"print"},{"value":"9781071634097","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3409-7_17","type":"book-chapter","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:03:24Z","timestamp":1691597004000},"page":"155-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intravitreal Injection of AAV for the Transduction of Mouse Retinal Ganglion Cells"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2065-2271","authenticated-orcid":false,"given":"Bart","family":"Nieuwenhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-2337","authenticated-orcid":false,"given":"Andrew","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.brainres.2007.01.116","volume":"1192","author":"Z-Z Bao","year":"2008","unstructured":"Bao Z-Z (2008) Intraretinal projection of retinal ganglion cell axons as a model system for studying axon navigation. Brain Res 1192:165\u2013177. https:\/\/doi.org\/10.1016\/j.brainres.2007.01.116","journal-title":"Brain Res"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/eye.2016.299","volume":"31","author":"TZ Khatib","year":"2017","unstructured":"Khatib TZ, Martin KR (2017) Protecting retinal ganglion cells. Eye 31:218\u2013224. https:\/\/doi.org\/10.1038\/eye.2016.299","journal-title":"Eye"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li C, Samulski RJ (2020) Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 21:255\u2013272. https:\/\/doi.org\/10.1038\/s41576-019-0205-4","journal-title":"Nat Rev Genet"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s40259-020-00453-8","volume":"34","author":"PI Fuller-Carter","year":"2020","unstructured":"Fuller-Carter PI, Basiri H, Harvey AR et al (2020) Focused update on AAV-based gene therapy clinical trials for inherited retinal degeneration. BioDrugs 34:763\u2013781. https:\/\/doi.org\/10.1007\/s40259-020-00453-8","journal-title":"BioDrugs"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","volume":"20","author":"DA Kuzmin","year":"2021","unstructured":"Kuzmin DA, Shutova MV, Johnston NR et al (2021) The clinical landscape for AAV gene therapies. Nat Rev Drug Discov 20:173\u2013174. https:\/\/doi.org\/10.1038\/d41573-021-00017-7","journal-title":"Nat Rev Drug Discov"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR et al (2021) Current clinical applications of in vivo gene therapy with AAVs. Mol Ther 29:464\u2013488. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.007","journal-title":"Mol Ther"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"809118","DOI":"10.3389\/fmed.2021.809118","volume":"8","author":"HKE Au","year":"2022","unstructured":"Au HKE, Isalan M, Mielcarek M (2022) Gene therapy advances: a meta-analysis of AAV usage in clinical settings. Front Med 8:809118","journal-title":"Front Med"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","volume":"30","author":"A Pupo","year":"2022","unstructured":"Pupo A, Fern\u00e1ndez A, Low SH et al (2022) AAV vectors: the Rubik\u2019s cube of human gene therapy. Mol Ther 30:3515\u20133541. https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.015","journal-title":"Mol Ther"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","volume":"28","author":"HC Verdera","year":"2020","unstructured":"Verdera HC, Kuranda K, Mingozzi F (2020) AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther 28:723\u2013746. https:\/\/doi.org\/10.1016\/j.ymthe.2019.12.010","journal-title":"Mol Ther"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/brv.12718","volume":"96","author":"M Whitehead","year":"2021","unstructured":"Whitehead M, Osborne A, Yu-Wai-Man P et al (2021) Humoral immune responses to AAV gene therapy in the ocular compartment. Biol Rev 96:1616\u20131644. https:\/\/doi.org\/10.1111\/brv.12718","journal-title":"Biol Rev"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino DE, Bushman FD, Chandler RJ et al (2022) Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol Ther 30:2646\u20132663. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.004","journal-title":"Mol Ther"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnana.2019.00093","volume":"13","author":"L Haery","year":"2019","unstructured":"Haery L, Deverman BE, Matho KS et al (2019) Adeno-associated virus technologies and methods for targeted neuronal manipulation. Front Neuroanat 13:93","journal-title":"Front Neuroanat"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coviro.2014.05.007","volume":"7","author":"L-Y Huang","year":"2014","unstructured":"Huang L-Y, Halder S, Agbandje-McKenna M (2014) Parvovirus glycan interactions. Curr Opin Virol 7:108\u2013118. https:\/\/doi.org\/10.1016\/j.coviro.2014.05.007","journal-title":"Curr Opin Virol"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"e00391","DOI":"10.1128\/JVI.00391-17","volume":"91","author":"S Pillay","year":"2017","unstructured":"Pillay S, Zou W, Cheng F et al (2017) Adeno-associated virus (AAV) serotypes have distinctive interactions with domains of the cellular AAV receptor. J Virol 91:e00391\u2013e00317. https:\/\/doi.org\/10.1128\/JVI.00391-17","journal-title":"J Virol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","volume":"10","author":"A Auricchio","year":"2001","unstructured":"Auricchio A, Kobinger G, Anand V et al (2001) Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet 10:3075\u20133081. https:\/\/doi.org\/10.1093\/hmg\/10.26.3075","journal-title":"Hum Mol Genet"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.visres.2007.08.009","volume":"48","author":"J Pang","year":"2008","unstructured":"Pang J, Lauramore A, Deng W et al (2008) Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vis Res 48:377\u2013385. https:\/\/doi.org\/10.1016\/j.visres.2007.08.009","journal-title":"Vis Res"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jgm.1126","volume":"10","author":"C Lebherz","year":"2008","unstructured":"Lebherz C, Maguire A, Tang W et al (2008) Novel AAV serotypes for improved ocular gene transfer. J Gene Med 10:375\u2013382. https:\/\/doi.org\/10.1002\/jgm.1126","journal-title":"J Gene Med"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/gt.2008.178","volume":"16","author":"M Hellstr\u00f6m","year":"2009","unstructured":"Hellstr\u00f6m M, Ruitenberg MJ, Pollett MA et al (2009) Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Gene Ther 16:521\u2013532. https:\/\/doi.org\/10.1038\/gt.2008.178","journal-title":"Gene Ther"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41434-019-0060-0","volume":"26","author":"X Cao","year":"2019","unstructured":"Cao X, Yung J, Mak H et al (2019) Factors governing the transduction efficiency of adeno-associated virus in the retinal ganglion cells following intravitreal injection. Gene Ther 26:109\u2013120. https:\/\/doi.org\/10.1038\/s41434-019-0060-0","journal-title":"Gene Ther"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","volume":"7","author":"J-Y Dong","year":"1996","unstructured":"Dong J-Y, Fan P-D, Frizzell RA (1996) Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 7:2101\u20132112. https:\/\/doi.org\/10.1089\/hum.1996.7.17-2101","journal-title":"Hum Gene Ther"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu Z, Yang H, Colosi P (2010) Effect of genome size on AAV vector packaging. Mol Ther 18:80\u201386. https:\/\/doi.org\/10.1038\/mt.2009.255","journal-title":"Mol Ther"},{"key":"17_CR22","doi-asserted-by":"publisher","unstructured":"Nieuwenhuis B, Laperrousaz E, Tribble JR et al (2023) Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene Ther 1\u201317. https:\/\/doi.org\/10.1038\/s41434-022-00380-z","DOI":"10.1038\/s41434-022-00380-z"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/gt.2016.66","volume":"23","author":"A Georgiadis","year":"2016","unstructured":"Georgiadis A, Duran Y, Ribeiro J et al (2016) Development of an optimized AAV2\/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. Gene Ther 23:857\u2013862. https:\/\/doi.org\/10.1038\/gt.2016.66","journal-title":"Gene Ther"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-6606-7-17","volume":"7","author":"J-H Choi","year":"2014","unstructured":"Choi J-H, Yu N-K, Baek G-C et al (2014) Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. Mol Brain 7:17. https:\/\/doi.org\/10.1186\/1756-6606-7-17","journal-title":"Mol Brain"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/hum.2016.140","volume":"28","author":"J Lu","year":"2017","unstructured":"Lu J, Williams JA, Luke J et al (2017) A 5\u2032 noncoding exon containing engineered intron enhances transgene expression from recombinant AAV vectors in vivo. Hum Gene Ther 28:125\u2013134. https:\/\/doi.org\/10.1089\/hum.2016.140","journal-title":"Hum Gene Ther"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1089\/10430349950016942","volume":"10","author":"JE Loeb","year":"1999","unstructured":"Loeb JE, Cordier WS, Harris ME et al (1999) Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 10:2295\u20132305. https:\/\/doi.org\/10.1089\/10430349950016942","journal-title":"Hum Gene Ther"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtn.2016.12.006","volume":"6","author":"MI Patr\u00edcio","year":"2017","unstructured":"Patr\u00edcio MI, Barnard AR, Orlans HO et al (2017) Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina. Mol Ther Nucleic Acids 6:198\u2013208. https:\/\/doi.org\/10.1016\/j.omtn.2016.12.006","journal-title":"Mol Ther Nucleic Acids"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ymthe.2017.07.011","volume":"25","author":"A Chaffiol","year":"2017","unstructured":"Chaffiol A, Caplette R, Jaillard C et al (2017) A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina. Mol Ther 25:2546\u20132560. https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.011","journal-title":"Mol Ther"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omtm.2017.04.003","volume":"5","author":"K Fujita","year":"2017","unstructured":"Fujita K, Nishiguchi KM, Shiga Y et al (2017) Spatially and temporally regulated NRF2 gene therapy using Mcp-1 promoter in retinal ganglion cell injury. Mol Ther Methods Clin Dev 5:130\u2013141. https:\/\/doi.org\/10.1016\/j.omtm.2017.04.003","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2017.00521","volume":"11","author":"KS Hanlon","year":"2017","unstructured":"Hanlon KS, Chadderton N, Palfi A et al (2017) A novel retinal ganglion cell promoter for utility in AAV vectors. Front Neurosci 11:521","journal-title":"Front Neurosci"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41598-018-19969-9","volume":"8","author":"CA Smith","year":"2018","unstructured":"Smith CA, Chauhan BC (2018) In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells. Sci Rep 8:1490. https:\/\/doi.org\/10.1038\/s41598-018-19969-9","journal-title":"Sci Rep"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/hum.2018.118","volume":"30","author":"EM Simpson","year":"2019","unstructured":"Simpson EM, Korecki AJ, Fornes O et al (2019) New MiniPromoter Ple345 (NEFL) drives strong and specific expression in retinal ganglion cells of mouse and primate retina. Hum Gene Ther 30:257\u2013272. https:\/\/doi.org\/10.1089\/hum.2018.118","journal-title":"Hum Gene Ther"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"16515","DOI":"10.1038\/s41598-020-73257-z","volume":"10","author":"S Millington-Ward","year":"2020","unstructured":"Millington-Ward S, Chadderton N, Berkeley M et al (2020) Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells. Sci Rep 10:16515. https:\/\/doi.org\/10.1038\/s41598-020-73257-z","journal-title":"Sci Rep"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","volume":"40","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhuang P, Huang H et al (2020) Mouse \u03b3-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells. J Neurosci 40:3896\u20133914. https:\/\/doi.org\/10.1523\/JNEUROSCI.0102-20.2020","journal-title":"J Neurosci"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/hgtb.2015.051","volume":"26","author":"B Strobel","year":"2015","unstructured":"Strobel B, Miller FD, Rist W et al (2015) Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications. Human Gene Ther Methods 26:147\u2013157. https:\/\/doi.org\/10.1089\/hgtb.2015.051","journal-title":"Human Gene Ther Methods"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"2200019","DOI":"10.1002\/bies.202200019","volume":"44","author":"L Belova","year":"2022","unstructured":"Belova L, Kochergin-Nikitsky K, Erofeeva A et al (2022) Approaches to purification and concentration of rAAV vectors for gene therapy. Bio Essays 44:2200019. https:\/\/doi.org\/10.1002\/bies.202200019","journal-title":"Bio Essays"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","volume":"22","author":"LC Chandler","year":"2021","unstructured":"Chandler LC, McClements ME, Yusuf IH et al (2021) Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina. Mol Ther Methods Clin Dev 22:52\u201365. https:\/\/doi.org\/10.1016\/j.omtm.2021.05.011","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.omtm.2019.08.013","volume":"15","author":"L Kondratova","year":"2019","unstructured":"Kondratova L, Kondratov O, Ragheb R et al (2019) Removal of endotoxin from rAAV samples using a simple detergent-based protocol. Mol Ther Methods Clin Dev 15:112\u2013119. https:\/\/doi.org\/10.1016\/j.omtm.2019.08.013","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17_CR39","unstructured":"(2015) Endotoxin testing recommendations for single-use intraocular ophthalmic devices; guidance for industry and food and drug administration staff; availability. In: Federal Register. https:\/\/www.federalregister.gov\/documents\/2015\/08\/17\/2015-20229\/endotoxin-testing-recommendations-for-single-use-intraocular-ophthalmic-devices-guidance-for. Accessed 24 Feb 2023"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.10.4.3","volume":"10","author":"YK Chan","year":"2021","unstructured":"Chan YK, Dick AD, Hall SM et al (2021) Inflammation in viral vector-mediated ocular gene therapy: a review and report from a workshop hosted by the Foundation Fighting Blindness, 9\/2020. Transl Vis Sci Technol 10:3. https:\/\/doi.org\/10.1167\/tvst.10.4.3","journal-title":"Transl Vis Sci Technol"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/sj.mt.6300389","volume":"16","author":"J Bennicelli","year":"2008","unstructured":"Bennicelli J, Wright JF, Komaromy A et al (2008) Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther 16:458\u2013465. https:\/\/doi.org\/10.1038\/sj.mt.6300389","journal-title":"Mol Ther"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/hgtb.2016.086","volume":"27","author":"MD Fischer","year":"2016","unstructured":"Fischer MD, Hickey DG, Singh MS et al (2016) Evaluation of an optimized injection system for retinal gene therapy in human patients. Human Gene Ther Methods 27:150\u2013158. https:\/\/doi.org\/10.1089\/hgtb.2016.086","journal-title":"Human Gene Ther Methods"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.omtm.2019.11.005","volume":"17","author":"MI Patr\u00edcio","year":"2020","unstructured":"Patr\u00edcio MI, Cox CI, Blue C et al (2020) Inclusion of PF68 surfactant improves stability of rAAV Titer when passed through a surgical device used in retinal gene therapy. Mol Ther Methods Clin Dev 17:99\u2013106. https:\/\/doi.org\/10.1016\/j.omtm.2019.11.005","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/B978-0-12-380920-9.00029-8","volume-title":"The laboratory rabbit, guinea pig, hamster, and other rodents","author":"J Silverman","year":"2012","unstructured":"Silverman J (2012) Chapter 29 \u2013 biomedical research techniques. In: Suckow MA, Stevens KA, Wilson RP (eds) The laboratory rabbit, guinea pig, hamster, and other rodents. Academic, Boston, pp 779\u2013795"},{"key":"17_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101143","volume":"3","author":"C-H Lin","year":"2022","unstructured":"Lin C-H, Sun YJ, Lee SH et al (2022) A protocol to inject ocular drug implants into mouse eyes. STAR Protoc 3:101143. https:\/\/doi.org\/10.1016\/j.xpro.2022.101143","journal-title":"STAR Protoc"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1167\/iovs.16-19701","volume":"57","author":"R Da Costa","year":"2016","unstructured":"Da Costa R, R\u00f6ger C, Segelken J et al (2016) A novel method combining vitreous aspiration and intravitreal AAV2\/8 injection results in retina-wide transduction in adult mice. Invest Ophthalmol Vis Sci 57:5326\u20135334. https:\/\/doi.org\/10.1167\/iovs.16-19701","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fncel.2018.00377","volume":"12","author":"ZJ Looser","year":"2018","unstructured":"Looser ZJ, Barrett MJP, Hirrlinger J et al (2018) Intravitreal AAV-delivery of genetically encoded sensors enabling simultaneous two-photon imaging and electrophysiology of optic nerve axons. Front Cell Neurosci 12:377","journal-title":"Front Cell Neurosci"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1041-8","volume":"9","author":"A Osborne","year":"2018","unstructured":"Osborne A, Khatib TZ, Songra L et al (2018) Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling. Cell Death Dis 9:1\u201318. https:\/\/doi.org\/10.1038\/s41419-018-1041-8","journal-title":"Cell Death Dis"},{"key":"17_CR49","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6317","volume":"7","author":"Y Katada","year":"2019","unstructured":"Katada Y, Kobayashi K, Tsubota K et al (2019) Evaluation of AAV-DJ vector for retinal gene therapy. PeerJ 7:e6317. https:\/\/doi.org\/10.7717\/peerj.6317","journal-title":"PeerJ"},{"key":"17_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031061","volume":"7","author":"J Rodger","year":"2012","unstructured":"Rodger J, Drummond ES, Hellstr\u00f6m M et al (2012) Long-term gene therapy causes transgene-specific changes in the morphology of regenerating retinal ganglion cells. PLoS One 7:e31061. https:\/\/doi.org\/10.1371\/journal.pone.0031061","journal-title":"PLoS One"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1038\/mtm.2016.78","volume":"3","author":"CJ LeVaillant","year":"2016","unstructured":"LeVaillant CJ, Sharma A, Muhling J et al (2016) Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF. Mol Ther Methods Clin Dev 3:16078. https:\/\/doi.org\/10.1038\/mtm.2016.78","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17_CR52","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3988","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J, Cai Y, Wu X et al (2021) Transcardiac perfusion of the mouse for brain tissue dissection and fixation. Bio Protocols 11:e3988. https:\/\/doi.org\/10.21769\/BioProtoc.3988","journal-title":"Bio Protocols"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"eabd2590","DOI":"10.1126\/sciadv.abd2590","volume":"7","author":"TZ Khatib","year":"2021","unstructured":"Khatib TZ, Osborne A, Yang S et al (2021) Receptor-ligand supplementation via a self-cleaving 2A peptide-based gene therapy promotes CNS axonal transport with functional recovery. Sci Adv 7:eabd2590. https:\/\/doi.org\/10.1126\/sciadv.abd2590","journal-title":"Sci Adv"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-0777-9_17","volume":"1162","author":"X Luo","year":"2014","unstructured":"Luo X, Yungher B, Park KK (2014) Application of tissue clearing and light sheet fluorescence microscopy to assess optic nerve regeneration in unsectioned tissues. Methods Mol Biol 1162:209\u2013217. https:\/\/doi.org\/10.1007\/978-1-4939-0777-9_17","journal-title":"Methods Mol Biol"},{"key":"17_CR55","doi-asserted-by":"publisher","unstructured":"Claybon A, Bishop AJR (2011) Dissection of a mouse eye for a whole mount of the retinal pigment epithelium. J Vis Exp:2563. https:\/\/doi.org\/10.3791\/2563","DOI":"10.3791\/2563"},{"key":"17_CR56","doi-asserted-by":"publisher","unstructured":"Ivanova E, Toychiev AH, Yee CW et al (2013) Optimized protocol for retinal wholemount preparation for imaging and immunohistochemistry. J Vis Exp:e51018. https:\/\/doi.org\/10.3791\/51018","DOI":"10.3791\/51018"},{"key":"17_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100879","volume":"2","author":"J Pang","year":"2021","unstructured":"Pang J, Thomas N, Tsuchiya D et al (2021) Step-by-step preparation of mouse eye sections for routine histology, immunofluorescence, and RNA in situ hybridization multiplexing. STAR Protocols 2:100879. https:\/\/doi.org\/10.1016\/j.xpro.2021.100879","journal-title":"STAR Protocols"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5334\/jors.342","volume":"9","author":"T Cross","year":"2021","unstructured":"Cross T, Navarange R, Son J-H et al (2021) Simple RGC: ImageJ plugins for counting retinal ganglion cells and determining the transduction efficiency of viral vectors in retinal Wholemounts. JORS 9:15. https:\/\/doi.org\/10.5334\/jors.342","journal-title":"JORS"},{"key":"17_CR59","unstructured":"How to take care of a syringe. https:\/\/www.hamiltoncompany.com\/laboratory-products\/syringe-knowledge-base\/syringe-care-and-use-guide. Accessed 24 Feb 2023"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nprot.2012.050","volume":"7","author":"MB Powner","year":"2012","unstructured":"Powner MB, Vevis K, McKenzie JAG et al (2012) Visualization of gene expression in whole mouse retina by in situ hybridization. Nat Protoc 7:1086\u20131096. https:\/\/doi.org\/10.1038\/nprot.2012.050","journal-title":"Nat Protoc"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000332802","volume":"79","author":"JFP Ullmann","year":"2012","unstructured":"Ullmann JFP, Moore BA, Temple SE et al (2012) The retinal Wholemount technique: a window to understanding the brain and behaviour. BBE 79:26\u201344. https:\/\/doi.org\/10.1159\/000332802","journal-title":"BBE"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0006-8993(02)04052-0","volume":"963","author":"G Chidlow","year":"2003","unstructured":"Chidlow G, Osborne NN (2003) Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res 963:298\u2013306. https:\/\/doi.org\/10.1016\/S0006-8993(02)04052-0","journal-title":"Brain Res"},{"key":"17_CR63","first-page":"1540","volume":"14","author":"I Surgucheva","year":"2008","unstructured":"Surgucheva I, Weisman AD, Goldberg JL et al (2008) Gamma-synuclein as a marker of retinal ganglion cells. Mol Vis 14:1540\u20131548","journal-title":"Mol Vis"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1167\/iovs.09-4098","volume":"51","author":"JMK Kwong","year":"2010","unstructured":"Kwong JMK, Caprioli J, Piri N (2010) RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest Ophthalmol Vis Sci 51:1052\u20131058. https:\/\/doi.org\/10.1167\/iovs.09-4098","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez AR, de Sevilla M\u00fcller LP, Brecha NC (2014) The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol 522:1411\u20131443. https:\/\/doi.org\/10.1002\/cne.23521","journal-title":"J Comp Neurol"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"226","DOI":"10.24272\/j.issn.2095-8137.2022.308","volume":"44","author":"FM Nadal-Nicol\u00e1s","year":"2023","unstructured":"Nadal-Nicol\u00e1s FM, Galindo-Romero C, Lucas-Ruiz F et al (2023) Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques. Zool Res 44:226\u2013248. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2022.308","journal-title":"Zool Res"}],"container-title":["Methods in Molecular Biology","Retinal Ganglion Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3409-7_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:05:30Z","timestamp":1691597130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3409-7_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071634080","9781071634097"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3409-7_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"10 August 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}